Middle East & Africa Blood Screening Market to 2032
Overview
The Middle East & Africa Blood Screening Market is expected to reach a 90.62 USD Million by 2032 and is projected to grow at a CAGR of 11.42% from 2025 to 2032.
Revenue, 2024 (USD Million)
46.36
Forecast, 2032 (USD Million)
90.62
CAGR, 2024 - 2032
11.42%
Report Coverage
Middle East & Africa
Middle East & Africa Blood Screening Market 2018-2032 USD Million
Middle East & Africa Blood Screening Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 46.36 USD Million
- Projected Market Size (2032): 90.62 USD Million
- CAGR (2025-2032): 11.42%
Key Findings of Middle East & Africa Blood Screening Market
- The Middle East & Africa Blood Screening Market was valued at 46.36 USD Million in 2024.
- The Middle East & Africa Blood Screening Market is likely to grow at a CAGR of 11.42% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Reagents & Kits in Products & Services Segment accounted for the largest share of the market with a revenue of 24.41 USD Million
- The fastest growing segment Next-Generation Sequencing (NGS) in Technology Segment grew Fastest with a CAGR of 12.29% during the forecast period from 2024 to 2032.
Middle East & Africa Blood Screening Market Scope
Middle East & Africa Blood Screening Market Segmentation & Scope
Disease Type
- Others
- HIV/AIDS
- Respiratory Diseases
- Infectious Diseases
- Cholesterol
- Cold & Flu
- Diabetes Mellitus
- Oncology
End User
- Ambulatory Surgical Centers
- Clinics
- Hospitals
- Blood Bank
- Diagnostic Centers
Products & Services
- Software & Services
- Instruments
- Reagents & Kits
Technology
- Others
- Western Blot Assay
- Nucleic Acid Test
- Next-Generation Sequencing (NGS)
- Rapid Tests
- Enzyme-Linked Immunosorbent Assay (ELISA)
Middle East & Africa Blood Screening Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 46.36 USD Million |
| Market Value in 2032 | 90.62 USD Million |
| CAGR (2025-2032) | 11.42% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Disease Type,End User,Products & Services,Technology |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 46.36 USD Million in 2024
- Key Country: RoMEA, leading in terms of revenue with value of 26.24 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Blood Screening Market to 2032, By Disease Type
- Oncology is the largest segment in Middle East & Africa Blood Screening Market to 2032 with a revenue of 18.65 USD Million in the year 2024.
- Diabetes Mellitus is the Fastest growing segment in Middle East & Africa Blood Screening Market to 2032 with a Growth rate of 12.10 % in forecast period 2025-2032.
-
Middle East & Africa Blood Screening Market to 2032, By End User
- Diagnostic Centers is the largest segment in Middle East & Africa Blood Screening Market to 2032 with a revenue of 17.63 USD Million in the year 2024.
- Diagnostic Centers is the Fastest growing segment in Middle East & Africa Blood Screening Market to 2032 with a Growth rate of 12.21 % in forecast period 2025-2032.
-
Middle East & Africa Blood Screening Market to 2032, By Products & Services
- Reagents & Kits is the largest segment in Middle East & Africa Blood Screening Market to 2032 with a revenue of 24.41 USD Million in the year 2024.
- Instruments is the Fastest growing segment in Middle East & Africa Blood Screening Market to 2032 with a Growth rate of 11.21 % in forecast period 2025-2032.
-
Middle East & Africa Blood Screening Market to 2032, By Technology
- Enzyme-Linked Immunosorbent Assay (ELISA) is the largest segment in Middle East & Africa Blood Screening Market to 2032 with a revenue of 18.94 USD Million in the year 2024.
- Next-Generation Sequencing (NGS) is the Fastest growing segment in Middle East & Africa Blood Screening Market to 2032 with a Growth rate of 11.83 % in forecast period 2025-2032.
Middle East & Africa Blood Screening Market Company Share Analysis
| Company Name |
|
||
| INNOVUS PHARMACEUTICALS, INC. | |||
| Pfizer Inc. | |||
| Bayer AG | |||
| Cipla Inc. | |||
| GSK plc. | |||
Middle East & Africa Blood Screening Market Geographical Sales Distribution, 2018-2032 USD Million
Middle East & Africa Blood Screening Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Blood Screening Market is segmented based on Segmentation Disease Type,End User,Products & Services,Technology.
Middle East & Africa Blood Screening Market was valued at USD 46.36(Revenue in USD Million) in 2022.
Middle East & Africa Blood Screening Market is projected to grow at a CAGR of 11.42% during the forecast period of 2024 to 2032.
The Reagents & Kits segment is expected to dominate the Middle East & Africa Blood Screening Market, holding a largest market share of 24.41 USD Million in 2024
Middle East & Africa Blood Screening Market Scope
Middle East & Africa Blood Screening Market Segmentation & Scope
Disease Type
- Others
- HIV/AIDS
- Respiratory Diseases
- Infectious Diseases
- Cholesterol
- Cold & Flu
- Diabetes Mellitus
- Oncology
End User
- Ambulatory Surgical Centers
- Clinics
- Hospitals
- Blood Bank
- Diagnostic Centers
Products & Services
- Software & Services
- Instruments
- Reagents & Kits
Technology
- Others
- Western Blot Assay
- Nucleic Acid Test
- Next-Generation Sequencing (NGS)
- Rapid Tests
- Enzyme-Linked Immunosorbent Assay (ELISA)
Frequently Asked Questions
The Middle East & Africa Blood Screening Market is segmented based on Segmentation Disease Type,End User,Products & Services,Technology.
Middle East & Africa Blood Screening Market was valued at USD 46.36(Revenue in USD Million) in 2022.
Middle East & Africa Blood Screening Market is projected to grow at a CAGR of 11.42% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Blood Screening Market for final year is USD 90.62 (USD Million).
Middle East & Africa Blood Screening Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Blood Screening Market is segmented based on Segmentation Disease Type,End User,Products & Services,Technology.
Middle East & Africa Blood Screening Market was valued at USD 46.36(Revenue in USD Million) in 2022.
Middle East & Africa Blood Screening Market is projected to grow at a CAGR of 11.42% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Blood Screening Market for final year is USD 90.62 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.